28Jun
[Audio] Episode 148 -- A Review of the Novartis and Alcon FCPA Enforcement Action
Even during this difficult time of the pandemic, economic uncertainty and social unrest, the Justice Department and the SEC have concluded a major FCPA enforcement action. Novartis and Alcon (which was a Novartis subsidiary at the time of the misconduct) agreed to pay a total of $345 million in criminal and civil penalties. Novartis spun off Alcon in 2019. Under the DOJ settlement, Novartis and Alcon each entered into a deferred prosecution agreement; Novartis agreed to pay a fine of $225...
By:
Michael Volkov
Source Url: https://www.jdsupra.com/legalnews/episode-148-a-review-of-the-novartis-40216/
Related
Governments all over the world are continuing to take steps to strengthen their powers to intervene ...
Read More >
The United States has been struggling to compete with its peers in securing nuclear power plant cons...
Read More >
Make no mistake, the antitrust laws remain in full effect. The leadership of the Antitrust Division...
Read More >
With costs coming down, a pre-existing supply chain, and other sites being developed nearby, Poland ...
Read More >
Dear YouDig? I am CEO of a mid-west manufacturing company. At long last, those extremely tough tim...
Read More >
To many employees, being written up is perceived as another way of being told that someone is the bo...
Read More >